Home / OracleBio Blog / Working With Multiplex Images

Working With Multiplex Images
19 August 2021
By John Waller

Imagine an image 20,000 times the file size of a standard iPhone photo… and imagine hundreds of these images having to be transferred, stored, and analysed to reveal their secrets.

That’s the reality and the challenge facing researchers working in the field of Quantitative Digital Pathology.

With some multiplex histopathology image files tipping the scales at 50-80GB in size, they create a headache for anyone wishing to work with these types of images.

To put it into perspective: simply storing 20 images at 50GB each will immediately fill up a 1TB Hard Drive! So it’s clear to see that dealing with images of this size requires a re-think when it comes to the computing requirements.

That’s why we decided to tackle this significant challenge; how to move, store and analyse large image files quickly and efficiently. We put our heads together and came up with a solution to adopt some pretty clever cloud-based computing techniques that can provide the flexibility and power required for such a task.

By combining advanced cloud storage and cloud computing, we’ve managed to streamline our image handling abilities and reduce processing times down from days to a matter of hours, even for the largest of multiplex images.

And that’s not all…we also built in parallel processing. So now the analysis of the whole sample set takes the same time as that of the largest single image, even for projects with 100s of images.

So this means that the data from those precious clinical samples can be made available to project teams in a fraction of the time.

Is your research being impacted by limited computational capabilities?

OracleBio can help in a number of ways – advice, deployment of cloud platforms, and all the computing power that OracleBio has at our disposal.

Please feel free to get in touch with us to arrange a chat.

Reasons to work with OracleBio:

  • Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard

  • Latest technologies – We continually invest time and money into the latest software and techniques so you don’t need to

About the Author: John Waller

Chief Operations Officer & Founder

John worked for a total of 15 years as a biology project leader for various pharmaceutical companies including AstraZeneca and Merck & Co. He has expertise in the integration of translational biomarkers into drug discovery programs and has considerable experience in developing in vitro, ex vivo and in vivo models involving image analysis across numerous therapeutic areas. 

Find out more about our Software Capabilities

OracleBio's Quantitative Digital Pathology Services

Stay up to date with OracleBio

Sign up to our mailing list to stay informed about news, webinars, events and more